Current & Future Oral Biologics Therapeutic Programs
Advancing oral biologic drug delivery across current and pipeline programs in oral insulin, GLP-1 therapies, peptide delivery, protein therapies, and multi-hormone treatments for improved oral bioavailability and chronic disease management.
Lead & Development Programs
Oral Insulin
Designed to more closely mimic physiologic insulin delivery
